- Avanti Polar Lipids

700 Industrial Park Drive
Alabaster, AL 35007
1-800-227-0651 or 205-663-2494
Fax 1-800-229-1004 or 205-663-0756
Orders • Technical Questions • General Information

Home

Catalog

	Synthetic Products
Ceramides - made from D-erythro-sphingosine
Purity >99%

N-Oleoyl-D-erythroSphingosine (C18:1 Ceramide)

Stability 1 year

Storage -20°C

Sphingolipid	MW	Catalog Number
Ceramide C2:0	341.53	860502	Product Data
Ceramide C4:0	369.59	860504	Product Data
Ceramide C6:0	397.64	860506	Product Data
Ceramide C8:0	425.7	860508	Product Data
Ceramide C10:0	453.75	860510	Product Data
Ceramide C12:0	481.8	860512	Product Data
Ceramide C14:0	509.86	860514	Product Data
Ceramide C16:0	537.91	860516	Product Data
Ceramide C17:0	551.94	860517	Product Data
Ceramide C18:0	565.96	860518	Product Data
Ceramide C18:1	563.95	860519	Product Data
Ceramide C20:0	594.02	860520	Product Data
Ceramide C24:0	650.13	860524	Product Data
Ceramide C24:1	648.11	860525	Product Data

References:

Mengubas K; Riordan FA; Bravery CA; Lewin J; Owens DL; Mehta AB; Hoffbrand AV; Wickremasinghe RG; (1999), Ceramideinduced killing of normal and malignant human lymphocytes is by a nonapoptotic mechanism. Oncogene, 18:15, 2499506
Hanna AN; Chan EY; Xu J; Stone JC; Brindley DN; (1999), A novel pathway for tumor necrosis factoralpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3kinase. J Biol Chem, 274:18, 127229